Xgeva (Denosumab)

Xgeva (denosumab) is a RANK ligand (RANKL) inhibitor used for:

• Reducing the occurrence of skeletal-related events in individuals with multiple myeloma and those with bone metastases from solid tumors.
  
• Treating adults and mature adolescents with a giant cell tumor of bone that cannot be surgically removed or where surgery may cause serious complications.
  
• Managing hypercalcemia of malignancy that doesn’t respond to bisphosphonate therapy.

Recommended Dosage: 

Multiple Myeloma and Bone Metastasis from Solid Tumors: The recommended dose of Xgeva is 120 mg administered as a shot under the skin every 4 weeks in the upper arm, thigh, or belly. Your doctor may also suggest taking calcium and vitamin D supplements to prevent low calcium levels.

Giant Cell Tumor of Bone: The recommended dose of Xgeva is 120 mg once every 4 weeks. In the first month of treatment, you’ll also get additional doses of 120 mg on Days 8 and 15. It’s given as a shot in your upper arm, upper thigh, or abdomen. Your doctor may also recommend taking calcium and vitamin D supplements to prevent low calcium levels.

Hypercalcemia of Malignancy: The recommended dose of Xgeva is 120 mg administered once every 4 weeks. In the first month of treatment, you’ll also get extra doses of 120 mg on Days 8 and 15. It’s injected just beneath the skin in the upper arm, upper thigh, or abdomen.

• Xgeva and Prolia both contain the common active ingredient, denosumab. If you’re taking Xgeva, you should not take Prolia at the same time.
  
• Serious allergic reactions, including anaphylaxis, can happen with Xgeva 120 mg/1.7 mL. If you have a severe allergic reaction, get medical help right away and stop using Xgeva permanently.
  
• Xgeva may lead to severe low calcium levels in the body. Before starting Xgeva treatment, make sure any existing low calcium levels are corrected. Keep an eye on calcium levels during Xgeva therapy, especially in the beginning, and provide calcium, magnesium, and vitamin D supplements if needed.
  
• Some patients taking Xgeva may develop jaw problems known as osteonecrosis of the jaw (ONJ), which can cause jaw pain, infections, and tooth issues. Before starting Xgeva and during treatment, it’s important to have a dental check-up and preventive care to lower the risk of ONJ.
  
• Stopping denosumab treatment may lead to multiple vertebral fractures (MVF). Patients at higher risk include those with osteoporosis or previous fractures. When stopping treatment with Xgeva, assess the patient’s risk for vertebral fractures.
  

What documents are required to import XGEVA to India?

XGEVA (denosumab) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients ID proof (issued by the government of India)
  

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable
  

XGEVA (denosumab injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Denosumab in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of XGEVA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Xgeva (denosumab) price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the XGEVA (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Xgeva®?

Denosumab is a Generic Name for the trade name drug Xgeva®.

What is the Manufacturer’s Name of Xgeva®?

Xgeva® is manufactured by Amgen Inc.

Is Xgeva® approved by the FDA?

Yes, Xgeva® is approved by the FDA. Date of first approval: November 18, 2010.

Where can I get Xgeva® at the best price in India?

To get the best Xgeva price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Xgeva®, a medical prescription is needed from a treating physician.

What is the dosage and form of Xgeva® supplied?

Xgeva® is supplied as an Injection: 120 mg/1.7 mL (70 mg/mL) solution in a single-dose vial for subcutaneous use. 

How much does Xgeva® cost in India?

The cost of Xgeva in India can vary. To procure this therapeutic drug legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Xgeva®?

Xgeva should be stored in its original carton in the refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Do not freeze. Protect from light. Once removed from the refrigerator, Xgeva can be stored at room temperature up to 77°F (25°C) for up to 14 days. 

Is it safe to buy Xgeva® online in India?

Yes, one can buy Xgeva online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Xgeva injections through legal channels.